BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32676392)

  • 1. Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.
    Peng Q; Zhou Y; Jin L; Cao C; Gao C; Zhou J; Yang D; Zhu J
    Transl Androl Urol; 2020 Jun; 9(3):1082-1098. PubMed ID: 32676392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel DNA methylation signature revealed GDF6 and RCC1 as potential prognostic biomarkers correlated with cell proliferation in clear cell renal cell carcinoma.
    Xu Z; Wu Y; Zhao G; Jin B; Jiang P
    Mol Biol Rep; 2023 Dec; 51(1):16. PubMed ID: 38087057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of m
    Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
    Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
    Zhang Z; Lin E; Zhuang H; Xie L; Feng X; Liu J; Yu Y
    Cancer Cell Int; 2020; 20():27. PubMed ID: 32002016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.
    Hou C; Cai H; Zhu Y; Huang S; Song F; Hou J
    Front Oncol; 2020; 10():558596. PubMed ID: 33178587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs.
    Yu Z; Lu C; Lu B; Gao H; Liang R; Xiang W
    BMC Genomics; 2023 Mar; 24(1):162. PubMed ID: 36991314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.
    Zhang L; Su Z; Hong F; Wang L
    Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
    Peng L; Liang J; Wang Q; Chen G
    Front Genet; 2022; 13():798846. PubMed ID: 35656315
    [No Abstract]   [Full Text] [Related]  

  • 9. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Han M; Li H
    Front Oncol; 2020; 10():707. PubMed ID: 32432045
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
    Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y
    Front Genet; 2022; 13():787884. PubMed ID: 35350243
    [No Abstract]   [Full Text] [Related]  

  • 11. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
    Zhao E; Bai X
    Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinoma.
    Zhu X; Ma X; Wu C
    Math Biosci Eng; 2021 Oct; 18(6):8559-8576. PubMed ID: 34814313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic signature predicts overall survival clear cell renal cell carcinoma.
    Wang Y; Chen L; Ju L; Qian K; Wang X; Xiao Y; Wang G
    Cancer Cell Int; 2020 Nov; 20(1):564. PubMed ID: 33292239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Zhao GJ; Wu Z; Ge L; Yang F; Hong K; Zhang S; Ma L
    Front Genet; 2021; 12():650416. PubMed ID: 34178024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients.
    Li Z; Du G; Zhao R; Yang W; Li C; Huang J; Wen Z; Li H; Zhang B
    Medicine (Baltimore); 2021 Oct; 100(39):e27374. PubMed ID: 34596153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma.
    Wang K; Yu M; Zhang Z; Yin R; Chen Q; Zhao X; Yu H
    Transl Cancer Res; 2023 May; 12(5):1270-1289. PubMed ID: 37304554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological functions and prognostic value of RNA Binding Proteins in clear cell Renal Cell Carcinoma.
    Zhu Z; He A; Lin L; Xu C; Cai T; Lin J
    J Cancer; 2020; 11(22):6591-6600. PubMed ID: 33046980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
    Jiang W; Guo Q; Wang C; Zhu Y
    Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
    Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
    Front Oncol; 2020; 10():788. PubMed ID: 32528886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.